wr 99210 has been researched along with sulfamethoxazole in 1 studies
| Studies (wr 99210) | Trials (wr 99210) | Recent Studies (post-2010) (wr 99210) | Studies (sulfamethoxazole) | Trials (sulfamethoxazole) | Recent Studies (post-2010) (sulfamethoxazole) |
|---|---|---|---|---|---|
| 59 | 0 | 12 | 5,813 | 680 | 1,216 |
| Protein | Taxonomy | wr 99210 (IC50) | sulfamethoxazole (IC50) |
|---|---|---|---|
| Dihydropteroate synthase | Escherichia coli K-12 | 4.7 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.7 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.1 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ager, AL; Canfield, CJ; Jacobus, DP; Lewis, NJ; Milhous, WK; Rossan, RN; Sweeney, TR | 1 |
1 other study(ies) available for wr 99210 and sulfamethoxazole
| Article | Year |
|---|---|
PS-15: a potent, orally active antimalarial from a new class of folic acid antagonists.
Topics: Administration, Oral; Animals; Antimalarials; Aotus trivirgatus; Atovaquone; Drug Synergism; Folic Acid Antagonists; Imides; Injections, Subcutaneous; Malaria, Falciparum; Mice; Naphthoquinones; Phenyl Ethers; Plasmodium falciparum; Proguanil; Sulfamethoxazole; Triazines | 1993 |